Theratechnologies Beta
Quel est le Beta de Theratechnologies?
Le Beta de Theratechnologies Inc. est 2.11
Quelle est la définition de Beta?
BETA indique si une action est plus ou moins volatile que le marché dans son ensemble. Un bêta inférieur à 1 indique que l'action est moins volatile que le marché, tandis qu'un bêta supérieur à 1 indique que l'action est plus volatile. La volatilité est mesurée par la fluctuation du prix autour de la moyenne.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta des entreprises dans Health Care secteur sur NASDAQ par rapport à Theratechnologies
Que fait Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Entreprises avec beta similaire à Theratechnologies
- Applied Materials a Beta de 2.11
- goeasy a Beta de 2.11
- Melcor Real Estate Investment Trust a Beta de 2.11
- THEMAC Resources a Beta de 2.11
- Nova Royalty a Beta de 2.11
- Vornado Realty Trust a Beta de 2.11
- Theratechnologies a Beta de 2.11
- Big Tree Carbon Inc a Beta de 2.11
- ENENSYS Technologies SA a Beta de 2.11
- Zillow Inc a Beta de 2.11
- Jadestone a Beta de 2.11
- Last Mile a Beta de 2.11
- Bid a Beta de 2.11